| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1011217928 |
| P356 | DOI | 10.1007/S10354-012-0117-9 |
| P8608 | Fatcat ID | release_t4ql4ohehzetzozbpnyruk3t5m |
| P698 | PubMed publication ID | 22688623 |
| P2093 | author name string | Robert H G Schwinger | |
| Hannes Reuter | |||
| P2860 | cites work | Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum | Q28266436 |
| SUMO1-dependent modulation of SERCA2a in heart failure | Q28508610 | ||
| Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure | Q34195822 | ||
| Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina | Q34547211 | ||
| Transmural heterogeneity and remodeling of ventricular excitation-contraction coupling in human heart failure | Q34999647 | ||
| Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. | Q36357779 | ||
| L-type calcium channel auto-regulation of transcription | Q37835944 | ||
| Oral levosimendan in patients with severe chronic heart failure --the PERSIST study | Q38572099 | ||
| Ca2+-dependent modulation of single human cardiac L-type calcium channels by the calcineurin inhibitor cyclosporine | Q40590858 | ||
| Adenylyl cyclase type VI corrects cardiac sarcoplasmic reticulum calcium uptake defects in cardiomyopathy | Q44970310 | ||
| Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure | Q46556129 | ||
| Altered stoichiometry of FKBP12.6 versus ryanodine receptor as a cause of abnormal Ca(2+) leak through ryanodine receptor in heart failure | Q73108723 | ||
| Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation | Q77306347 | ||
| The Na+-Ca2+ exchanger is essential for the action of cardiac glycosides | Q77678864 | ||
| P433 | issue | 13-14 | |
| P921 | main subject | heart failure | Q181754 |
| P304 | page(s) | 297-301 | |
| P577 | publication date | 2012-06-12 | |
| P1433 | published in | Wiener Medizinische Wochenschrift | Q2568998 |
| P1476 | title | Calcium handling in human heart failure--abnormalities and target for therapy | |
| P478 | volume | 162 |
| Q27021919 | Clinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem Cells |
| Q37731285 | Enhanced store-operated Ca2+ influx and ORAI1 expression in ventricular fibroblasts from human failing heart |
| Q48448938 | Pivotal role of α2 Na+ pumps and their high affinity ouabain binding site in cardiovascular health and disease |
| Q37599625 | Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris. |
| Q37375441 | The NO/ONOO-cycle as the central cause of heart failure |
Search more.